Am J Health Syst Pharm. 2010;67(10):806-809. The patient had no signs or symptoms of retroperitoneal hematoma until she became acutely hypotensive approximately 48 hours after the administration ...

Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated ...

Purpose. A case of fatal retroperitoneal hematoma that developed after enoxaparin administration in a woman with paroxysmal atrial flutter and chest pain is reported. Summary. A 63-year-old ...